参考文献/References:
［1］Teede HJ,Misso ML，Costello MF， et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome［J］. Fertil Steril，2018,110 (3): 364-379.
［2］Stepto N K, Cassar S, Joham A E, et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp ［J］. Human Reproduction, 2013, 28(3): 777-784.
［3］Legro R S， Kunselman A R， Dodson W C， et al. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women ［J］. J Clin Endocrinol Metab, 1999, 84 (1):165-169.
［4］Balen A H， Conway G S， Kaltsas G， et al. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients ［J］. Human Reproduction, 1995, 10 (8):2107-2111.
［5］Kiddy D S， Sharp P S， White D M， et al. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases ［J］. Clinical Endocrinolog, 1990，32 (2): 213-220.
［6］Ehrmann D A, Liljenquist D R, Kasza K, et al. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome［J］. The Journal of Clinical Endocrinology and Metabolism, 2006, 91(1): 48-53.
［7］Clark A, Thornley B， Tomlinson L, et al. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment ［J］. Human Reproduction, 1998，13 (6): 1502-1505.
［8］Huber-buchholz M C, NORMAN R. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome:Role of insulin sensitivity and luteinizing hormone［J］. Journal of Clinical Endocrinology & Metabolism, 1999, 84 (4): 1470-1474.
［9］Moran L J, Norkes M, Clifton P M, et al. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome ［J］. The Journal of Clinical Endocrinology and Metabolism, 2003, 88(2): 812-819.
［10］Thomson R L, Buckley J D, LIM S S, et al. Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome ［J］. Fertility and Sterility, 2010, 94 (5): 1812-1816.
［11］Glueck C J, Dharashivkar S, WANG P, et al. Obesity and extreme obesity, manifest by ages 20~24 years, continuing through 32~41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy ［J］. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2005, 122(2):206-212.
［12］Teede Helena,Deeks Amanda,Gibson-Helm, et al. Body mass index as a predictor of polycystic ovary syndrome risk: Results of a longitudinal cohort study［EB/OL］.Doi：10.1210/endo-meetings.2010.PART2.P 9.P 2-414.
［13］Hutchison S K, Stepto N K, Harrison C L, et al. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome ［J］. Journal of Clinical Endocrinology & Metabolism, 2011, 96 (1): E 48-E 56.
［14］Poehlman E T, Dvorak R V, Denino W F, et al. Effects of resistance training and endurance training on insulin sensitivity in nonobese, young women: A controlled randomized trial ［J］. Journal of Clinical Endocrinology & Metabolism, 2000, 85 (7): 2463-2468.
［15］Ross, Robert. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men ［J］. Annals of Internal Medicine, 2000,133 (2): 92-103.
［16］Moran L J, Hutchison S K, Norman R J, et al. Lifestyle changes in women with polycystic ovary syndrome ［J］. The Cochrane Database of Systematic Reviews, 2011 (2):CD 007506.
相似文献/References:
[1]姜荣华,钟小英,潘萍,等.61例多囊卵巢综合征妇女行供精人工授精结局分析[J].中国计划生育和妇产科,2011,(04):0.
JIANG Rong-hua,ZHONG Xiao-ying,PAN Ping.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(2):0.
[2]任涛,熊小英,蔡春芳,等.多囊卵巢综合征患者视黄醇结合蛋白-4的水平变化及意义[J].中国计划生育和妇产科,2013,(04):0.
REN Tao *,XIONG Xiao-ying,CAI Chun-fang.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(2):0.
[3]龚衍,曾玖芝,李运星,等.不同剂量来曲唑对多囊卵巢综合征不孕症患者诱导排卵的临床观察[J].中国计划生育和妇产科,2013,(05):0.
GONG Yan,ZENG Jiu-zhi,Li Yun-xing,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(2):0.
[4]黄引平.子痫前期与代谢性疾病[J].中国计划生育和妇产科,2014,(01):0.
HUANG Yin-ping,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[5]李琳.无生育要求多囊卵巢综合征患者无排卵的处理[J].中国计划生育和妇产科,2014,(04):0.
LI Lin,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[6]刘振腾,郝翠芳.有生育要求的多囊卵巢综合征患者的治疗[J].中国计划生育和妇产科,2014,(04):0.
LIU Zhen-teng,HAO Cui-fang,Reproductive Medical Center,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[7]李淑红.腹腔镜下卵巢表面电凝术治疗多囊卵巢综合征的疗效分析[J].中国计划生育和妇产科,2014,(04):0.
LI Shu-hong,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[8]倪仁敏,杨冬梓.多囊卵巢综合征的发病概况[J].中国计划生育和妇产科,2014,(06):0.
[9]崔琳琳,陈子江.多囊卵巢综合征的临床诊断要点[J].中国计划生育和妇产科,2014,(06):0.
[10]刘义.多囊卵巢综合征长期管理与治疗策略[J].中国计划生育和妇产科,2014,(06):0.
[11]杨纨,王海燕*.多囊卵巢综合征与复发性流产[J].中国计划生育和妇产科,2017,(10):1.
[12]蒋朝阳,马天仲*.硫氧还蛋白互相作用蛋白在生殖系统的研究进展[J].中国计划生育和妇产科,2018,(3):23.